| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 556* | 2021 |
| A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction F Klevebro, GA von Döbeln, N Wang, G Johnsen, AB Jacobsen, ... Annals of Oncology 27 (4), 660-667, 2016 | 399 | 2016 |
| Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro … K Kumagai, I Rouvelas, JA Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, ... Journal of British Surgery 101 (4), 321-338, 2014 | 245 | 2014 |
| Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial GA von Döbeln, F Klevebro, AB Jacobsen, HO Johannessen, NH Nielsen, ... Diseases of the Esophagus 32 (2), doy078, 2019 | 146 | 2019 |
| Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: a randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant … F Klevebro, G Johnsen, E Johnson, A Viste, T Myrnäs, E Szabo, ... European Journal of Surgical Oncology (EJSO) 41 (7), 920-926, 2015 | 121 | 2015 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 101 | 2022 |
| Cardiorespiratory comorbidity and postoperative complications following esophagectomy: a European multicenter cohort study F Klevebro, JA Elliott, A Slaman, BD Vermeulen, S Kamiya, C Rosman, ... Annals of surgical oncology 26, 2864-2873, 2019 | 62 | 2019 |
| Lasting symptoms after esophageal resection (LASER): European multicenter cross-sectional study SR Markar, G Zaninotto, C Castoro, A Johar, P Lagergren, JA Elliott, ... Annals of surgery 275 (2), e392-e400, 2022 | 59 | 2022 |
| Risk prediction model of 90-day mortality after esophagectomy for cancer XB D’journo, D Boulate, A Fourdrain, A Loundou, ... JAMA surgery 156 (9), 836-845, 2021 | 55 | 2021 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 43 | 2021 |
| Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry F Klevebro, M Lindblad, J Johansson, L Lundell, M Nilsson Journal of British Surgery 103 (13), 1864-1873, 2016 | 40 | 2016 |
| Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer–review article F Klevebro, S Ekman, M Nilsson Surgical oncology 26 (3), 290-295, 2017 | 39 | 2017 |
| Assessment of health related quality of life and digestive symptoms in long-term, disease free survivors after esophagectomy PR Boshier, F Klevebro, KV Savva, A Waller, L Hage, GB Hanna, DE Low Annals of surgery 275 (1), e140-e147, 2022 | 38 | 2022 |
| Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group BJ Van Der Wilk, ERC Hagens, BM Eyck, SS Gisbertz, ... British Journal of Surgery 109 (3), 283-290, 2022 | 37 | 2022 |
| Surgical morbidity and mortality from the multicenter randomized controlled NeoRes II trial: standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for … K Nilsson, F Klevebro, I Rouvelas, M Lindblad, E Szabo, I Halldestam, ... Annals of surgery 272 (5), 684-689, 2020 | 32 | 2020 |
| Application of standardized hemodynamic protocols within enhanced recovery after surgery programs to improve outcomes associated with anastomotic leak and conduit necrosis in … F Klevebro, PR Boshier, DE Low Journal of Thoracic Disease 11 (Suppl 5), S692, 2019 | 29 | 2019 |
| Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial) B Sunde, F Klevebro, A Johar, G Johnsen, AB Jacobsen, NI Glenjen, ... Journal of British Surgery 106 (11), 1452-1463, 2019 | 25 | 2019 |
| Comparison of costs and short-term clinical outcomes of per-oral endoscopic myotomy and laparoscopic Heller myotomy A Wirsching, PR Boshier, F Klevebro, SJ Kaplan, MFJ Seesing, ... The American Journal of Surgery 218 (4), 706-711, 2019 | 23 | 2019 |
| Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a … F Klevebro, K Nilsson, M Lindblad, S Ekman, J Johansson, L Lundell, ... Diseases of the Esophagus 33 (5), doz078, 2020 | 22 | 2020 |
| Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction F Klevebro, A Tsekrekos, D Low, L Lundell, M Vieth, S Detlefsen Diseases of the Esophagus 33 (6), doaa005, 2020 | 21 | 2020 |
